# The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells

**Authors:** Tin Myo Khing, Won Seok Choi, Dong Min Kim, Wah Wah Po, Wynn Thein, Chang Yell Shin, Uy Dong Sohn

PMC · DOI: 10.1038/s41598-021-02503-9 · 2021-12-06

## TL;DR

This study shows how paclitaxel causes cell death in AGS gastric cancer cells through mitotic catastrophe, autophagy, and apoptosis.

## Contribution

The paper identifies mitotic catastrophe as a key mechanism of paclitaxel-induced cell death in AGS cells, alongside apoptosis and autophagy.

## Key findings

- Paclitaxel activates intrinsic apoptosis via caspase-3, caspase-9, and PARP in AGS cells.
- Paclitaxel induces autophagy, as shown by increased LC3B-II, Atg5, and Beclin-1 levels.
- Paclitaxel causes mitotic catastrophe and G2/M phase arrest, leading to cell death within 48 hours.

## Abstract

Paclitaxel is an anti-microtubule agent that has been shown to induce cell death in gastric cancer. However, the detailed mechanism of action is unclear. In this study, we reveal that the paclitaxel-induced cell death mechanism involves mitotic catastrophe, autophagy and apoptosis in AGS cells. Paclitaxel induced intrinsic apoptosis by activating caspase-3, caspase-9 and PARP. In addition, the significant increase in autophagy marker LC3B-II, together with Atg5, class III PI3K and Beclin-1, and the down-regulation of p62 following paclitaxel treatment verified that paclitaxel induced autophagy. Further experiments showed that paclitaxel caused mitotic catastrophe, cell cycle arrest of the accumulated multinucleated giant cells at the G2/M phase and induction of cell death in 24 h. Within 48 h, the arrested multinucleated cells escaped mitosis by decreasing cell division regulatory proteins and triggered cell death. Cells treated with paclitaxel for 48 h were grown in fresh medium for 24 h and checked for CDC2, CDC25C and lamin B1 protein expressions. These proteins had decreased significantly, indicating that the remaining cells became senescent. In conclusion, it is suggested that paclitaxel-induced mitotic catastrophe is an integral part of the cell death mechanism, in addition to apoptosis and autophagy, in AGS cells.

## Linked entities

- **Genes:** Casp3 (caspase 3) [NCBI Gene 12367], Casp9 (caspase 9) [NCBI Gene 12371], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], ATG5 (autophagy related 5) [NCBI Gene 9474], BECN1 (beclin 1) [NCBI Gene 8678], GTF2H1 (general transcription factor IIH subunit 1) [NCBI Gene 2965], CDK1 (cyclin dependent kinase 1) [NCBI Gene 983], CDC25C (cell division cycle 25C) [NCBI Gene 995], Lam (Lamin) [NCBI Gene 33782]
- **Chemicals:** paclitaxel (PubChem CID 36314)
- **Diseases:** gastric cancer (MONDO:0001056)

## Full-text entities

- **Genes:** ATG16L1 (autophagy related 16 like 1) [NCBI Gene 55054] {aka APG16L, ATG16A, ATG16L, IBD10, WDR30}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}, MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, FADD (Fas associated via death domain) [NCBI Gene 8772] {aka GIG3, IMD90, MORT1}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, CCNL2 (cyclin L2) [NCBI Gene 81669] {aka ANIA-6B, CCNM, CCNS, HCLA-ISO, HLA-ISO, PCEE}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, CCNB1 (cyclin B1) [NCBI Gene 891] {aka CCNB}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, Cdc25c (cell division cycle 25C) [NCBI Gene 12532] {aka Cdc25}, TNFRSF10B (TNF receptor superfamily member 10b) [NCBI Gene 8795] {aka CD262, DR5, KILLER, KILLER/DR5, TRAIL-R2, TRAILR2}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, cytochrome c [NCBI Gene 108838674], Lmnb1 (lamin B1) [NCBI Gene 16906], CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, CDC25C (cell division cycle 25C) [NCBI Gene 995] {aka CDC25, PPP1R60}, actin [NCBI Gene 108862827], CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, Ccnb1 (cyclin B1) [NCBI Gene 268697] {aka Ccnb1-rs1, Ccnb1-rs13, CycB1, Cycb-4, Cycb-5, Cycb1-rs1}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, HLA-DRB4 (major histocompatibility complex, class II, DR beta 4) [NCBI Gene 3126] {aka DR4, DRB4, HLA-DR4B, HLA-DRB, HLA-DRB4*}
- **Diseases:** death (MESH:D003643), breast cancer (MESH:D001943), cytotoxic (MESH:D064420), non-small cell lung cancer (MESH:D002289), Cancer (MESH:D009369), prostate cancer (MESH:D011471), Kaposi sarcoma (MESH:D012514), necrotic (MESH:D009336), AIDS (MESH:D000163), aneuploidy (MESH:D000782), Gastric cancer (MESH:D013274), leukaemia (MESH:D015458), ovarian cancer (MESH:D010051)
- **Chemicals:** acrylamide (MESH:D020106), Paclitaxel (MESH:D017239), Triton X-100 (MESH:D017830), formazan (MESH:D005562), propidium iodide (MESH:D011419), paraformaldehyde (MESH:C003043), DMSO (MESH:D004121), EDTA (MESH:D004492), zVAD-fmk (MESH:C096713), SDS (MESH:D012967), methanol (MESH:D000432), phosphatidylserine (MESH:D010718), etoposide (MESH:D005047), Acridine orange (MESH:D000165), Baf (MESH:C012071), DPBS (-), amphotericin B (MESH:D000666), water (MESH:D014867), PBS (MESH:D007854), DAPI (MESH:C007293), penicillin (MESH:D010406), TBS (MESH:D013725), camptothecin (MESH:D002166), 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MESH:C022616), MTT (MESH:C070243), Tween-20 (MESH:D011136), streptomycin (MESH:D013307), DTT (MESH:D004229), ice (MESH:D007053), 3-MA (MESH:C025946), ethanol (MESH:D000431), CO2 (MESH:D002245),  (MESH:D000970)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** KCLB 21739 — Homo sapiens (Human), Transformed cell line (CVCL_0Z86), P39 — Homo sapiens (Human), Adult acute myeloid leukemia with maturation, Cancer cell line (CVCL_0478), SGC-7901 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0520), AGS — Homo sapiens (Human), Gastric adenocarcinoma, Cancer cell line (CVCL_0139), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), NCI-H460 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0459)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8648765/full.md

---
Source: https://tomesphere.com/paper/PMC8648765